Overview Request Sample Pages Request Customization Download PDF
You are viewing: Asia Pacific Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The Asia Pacific Gastrointestinal Stent Market was valued at $147.6 Million in 2026 and projected to reach to $207.9 Million by 2031, representing a compound annual growth rate of 7.1%. The Asia Pacific gastrointestinal stent market is positioned for sustained growth, expanding from USD 147.6 million in 2026 to USD 207.9 million by 2031.

Asia Pacific Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Gastrointestinal Stent Market Trends and Insights

  • Asia Pacific's market growth outpaces the global average, driven by rising prevalence of gastrointestinal disorders, increasing healthcare infrastructure investment, and growing adoption of minimally invasive procedures across the region.
  • Asia Pacific's aging population and improving access to advanced endoscopic technologies are key catalysts accelerating market penetration. Asia Pacific represents a high-growth opportunity within the global gastrointestinal stent landscape, with a compound annual growth rate of 7.1% over the forecast period.
  • The region's expanding middle class, coupled with enhanced reimbursement policies in developed markets like Japan, South Korea, and Australia, is driving demand for both metallic and plastic stent solutions.
  • Asia Pacific's healthcare systems are increasingly prioritizing cost-effective treatment alternatives, positioning gastrointestinal stents as a preferred intervention for biliary, esophageal, and colorectal applications..

Key Market Statistics

  • CAGR (2026-2031) 7.1% CAGR
  • Market Size, 2026 ~USD 147.6 Million
  • Forecast, 2031 ~USD 207.9 Million
  • Geography Asia Pacific

Asia Pacific Gastrointestinal Stent Market Overview

Outpacing Global Growth :

Asia Pacific's gastrointestinal stent market grows at 7.1% CAGR, significantly exceeding the global average of 5.7%, reflecting strong regional demand and market maturation.

Rising GI Disorder Prevalence :

Increasing incidence of gastrointestinal diseases across Asia Pacific, driven by aging populations, dietary changes, and lifestyle factors, is fueling demand for stent interventions.

Healthcare Infrastructure Expansion :

Substantial investments in medical infrastructure and hospital modernization across China, India, Japan, and Southeast Asia are enabling wider adoption of advanced stenting procedures.

Minimally Invasive Procedure Adoption :

Growing preference for minimally invasive endoscopic treatments over traditional surgery is accelerating gastrointestinal stent utilization throughout the Asia Pacific region.

Asia Pacific Gastrointestinal Stent Market Dynamics

  • This trajectory reflects the region's increasing healthcare spending, improving diagnostic capabilities, and rising patient awareness of minimally invasive treatment options.
  • Key markets including China, Japan, and India are driving expansion through enhanced endoscopic infrastructure and clinical adoption. Regional growth is supported by favorable demographic trends, including an aging population susceptible to GI disorders, and improving reimbursement policies across developed and emerging markets.
  • Strategic investments by medical device manufacturers and partnerships with regional healthcare providers are expected to further accelerate market penetration, particularly in underserved Southeast Asian markets..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Asia Pacific gastrointestinal stent market will grow from USD 147.6M (2026) to USD 207.9M (2031) at a 7.1% CAGR, outpacing global growth.
    • Asia Pacific's aging demographics and rising gastrointestinal disease burden are primary drivers of stent adoption across the region.
    • Asia Pacific markets in Japan, South Korea, and Australia lead adoption due to advanced healthcare infrastructure and favorable reimbursement frameworks.
    • Asia Pacific's shift toward minimally invasive endoscopic procedures is accelerating demand for both self-expanding metal stents and plastic alternatives.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    Asia Pacific Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Asia Pacific market intelligence to develop region-specific product portfolios, establish distribution networks, and capitalize on the 7.1% CAGR growth opportunity across emerging and developed markets.
    • Healthcare Investors & PE Firms : Investors require detailed market sizing and growth forecasts for Asia Pacific to evaluate investment opportunities in GI stent companies, hospital networks, and medical device distributors with strong regional exposure.
    • Hospital & Healthcare Providers : Healthcare systems need market data to inform procurement strategies, budget planning, and technology adoption decisions for gastrointestinal stent programs across Asia Pacific facilities.
    • Market Research & Consulting Firms : Research organizations require comprehensive Asia Pacific market analysis to support client advisory services, competitive benchmarking, and strategic planning for healthcare and medical device sectors.
    • Regulatory & Policy Bodies : Government agencies and health authorities need market intelligence to inform healthcare policy, reimbursement frameworks, and medical device regulations aligned with Asia Pacific market dynamics and clinical needs.

    Key Companies in the Asia Pacific Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 318.6 Million · 5.5% wtd CAGR ·
    Europe
    ~USD 218.3 Million · 5.2% wtd CAGR ·
    Latin America
    ~USD 49.9 Million · 4.6% wtd CAGR ·
    Middle East & Africa
    ~USD 21.9 Million · 3.1% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    ChinaUSD 79.65 Million
    JapanUSD 56.62 Million
    IndiaUSD 26.14 Million
    South KoreaUSD 17.71 Million
    AustraliaUSD 12.92 Million
    ThailandUSD 4.81 Million
    New ZealandUSD 3.17 Million
    Rest Of Asia PacificUSD 6.91 Million

    Country market size visualization

    China
    USD 79.65 Million
    Japan
    USD 56.62 Million
    India
    USD 26.14 Million
    South Korea
    USD 17.71 Million
    Australia
    USD 12.92 Million
    Thailand
    USD 4.81 Million
    New Zealand
    USD 3.17 Million
    Rest Of Asia Pacific
    USD 6.91 Million

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasts : Obtain precise market valuations for Asia Pacific (USD 147.6M in 2026, USD 207.9M in 2031) with country-level breakdowns for China, Japan, India, and other key markets to inform regional expansion strategies.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning specific to Asia Pacific, enabling targeted go-to-market strategies and partnership identification across the region.
    • Growth Driver Analysis : Identify region-specific growth catalysts including healthcare infrastructure investments, regulatory changes, and disease prevalence trends driving the 7.1% CAGR outperformance versus global markets.
    • Country-Level Market Insights : Access granular data on individual Asia Pacific markets to prioritize market entry, resource allocation, and localization efforts based on market maturity and growth potential.
    • Strategic Investment Guidance : Leverage comprehensive Asia Pacific market analysis to support investment decisions, M&A strategies, and product development roadmaps aligned with regional demand and clinical needs.

    Frequently asked questions

    What is the projected market size for gastrointestinal stents in Asia Pacific by 2031?

    Asia Pacific's gastrointestinal stent market is projected to reach USD 207.9 million by 2031, up from USD 147.6 million in 2026.

    What is the CAGR for the Asia Pacific gastrointestinal stent market?

    Asia Pacific's gastrointestinal stent market is expected to grow at a compound annual growth rate of 7.1% between 2026 and 2031.

    Which countries in Asia Pacific are driving gastrointestinal stent market growth?

    Asia Pacific's leading markets include Japan, South Korea, and Australia, where advanced healthcare systems and reimbursement policies support higher stent adoption rates.

    What types of gastrointestinal stents are most commonly used in Asia Pacific?

    Asia Pacific healthcare providers utilize both self-expanding metal stents (SEMS) and plastic stents, with selection depending on clinical indication and patient factors.

    What factors are driving growth in Asia Pacific's gastrointestinal stent market?

    Asia Pacific's market growth is driven by aging populations, rising gastrointestinal disease prevalence, expanding healthcare infrastructure, and increasing adoption of minimally invasive endoscopic procedures.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status